{
    "code": "52027952",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027952",
    "time": "2021-07-30 03:17:32",
    "許可證字號": "衛部藥輸字第027952號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/14",
    "發證日期": "109\/09\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202795200",
    "中文品名": "歐健體斯膠囊50毫克",
    "英文品名": "Ongentys 50mg Hard Capsules",
    "適應症": "表現藥效終期運動功能波動現象(end-of-dose motor fluctuations)，以左多巴\/多巴脫羧基酶抑制劑(levodopa\/DOPA decarboxylase inhibitors)無法達到穩定治療效果之巴金森氏症成人病人的輔助治療。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒OPA\/Al\/PVC\/Al blisters鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/09\/14",
    "主成分略述": "opicapone",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1407301100  台灣美強股份有限公司",
    "申請商地址": "台北市中山區南京東路二段66號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "FPT0018100  Bial-Portela &amp; Companhia, S.A.",
            "製造廠廠址": "Av. da Siderurgia Nacional, Apartado 19, S. Mamede do Coronado, 4745-457, Portugal",
            "製造廠公司地址": "",
            "製造廠國別": "PORTUGAL",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208007000",
            "成分名稱": "opicapone",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部藥輸字第027952號_仿單-109-08-25-109-11-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027952&Seq=001&Type=9"
        },
        {
            "title": "衛部藥輸字第027952號_鋁箔外盒-109-08-25-109-11-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027952&Seq=001&Type=8"
        }
    ]
}